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A B S T R A C T   
Background: South Asians have increased cardiovascular risk burden but little data exists comparing cardio-
vascular (CV) risk models in migrant and native South Asians. Our retrospective cohort study in patients pre-
senting with first acute myocardial infarction(MI) compares the predictive value of CV risk scores in native and 
UK migrant South Asians. 
Methods: Retrospective cohort study of 80 UK-based patients of South Asian origin admitted with first presen-
tation MI, excluding patients with known coronary artery disease. A retrospective 10-year CV risk was calculated 
for each patient using four cardiovascular risk models: Framingham Risk Score(RiskFRS), World Health Organi-
sation(RiskWHO), American College of Cardiology/American Heart Association(ACC/AHA) (RiskACC/AHA), and 
3rdJoint British Societies’(RiskJBS). Our aim was to assess agreement between these risk scores and conduct 
comparative analysis with native South Asians. 
Results: RiskJBS identified the largest proportion of migrant South Asians as ‘high risk’ with 65% of subjects 
having an estimated >20% 10-year CV risk. RiskWHO provided the lowest 10-year CV risk estimates for South 
Asian migrants, identifying 21.25% of the migrant cohort as >20% risk of major CV event. Comparative analysis 
with the native South Asian cohort demonstrated RiskJBS as the risk model most likely to identify patients as 
‘high’(>20%) risk(55.9%; p  0.224). 
Conclusions: This study represents the first analysis of predictive cardiovascular risk scores comparing migrant 
and native South Asian populations. Significant variation between the CV risk scores were observed, leading to 
inaccuracies in patient cardiovascular risk estimation. Given the growing burden of cardiovascular disease in 
Asian countries and different population characteristics, we highlight the need for population specific CV disease 
risk models whilst providing stimulus for further large-scale prospective studies.   
1. Introduction 
Cardiovascular disease (CVD) remains the leading cause of mortality 
and morbidity, with estimates that mortality will increase more than 
25% by 2030 (Global et al., 2015; Laslett et al., 2012). The South Asian 
population (India, Pakistan, Bangladesh, Nepal, Sri Lanka) represents 
approximately one quarter of the world’s population. South Asians are 
recognised to have an increased risk of premature CVD, with an 
age-standardised mortality around 40% (Balarajan, 1996; Reddy, 2004; 
Reddy & Yusuf, 1998). Through a combination of environmental and 
genetic factors, their enhanced susceptibility to CVD is associated with 
development of cardiovascular risk factors at an earlier age (Gupta & 
Brister, 2006; Joshi et al., 2007). 
Accurate assessment of CVD risk helps to target risk reduction stra-
tegies, with the objective of reducing or preventing cardiovascular 
related morbidity and mortality. Multi-variant risk assessment models 
guide decision making through estimating the probability of cardio-
vascular events in asymptomatic individuals. Data from North American 
and European observational studies have informed these cardiovascular 
risk scores (Goff et al., 2013a; Hippisley-Cox et al., 2007; Wilson et al., 
1998), with a paucity of data in South Asian populations (Ranganathan 
& Bhopal, 2006). The cardiovascular risk scores currently used in clin-
ical practice have largely been derived from Caucasian populations. The 
most recent cardiovascular risk score, the 3rd Joint British Societies’ risk 
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calculator (RiskJBS), represents and incorporates data from QRISK 
(QRESEARCH database) and QRISK2 (THIN-database), included 96% 
and 98% Caucasian patients respectively in their derivations and vali-
dations. Given the low proportion of South Asian patients within the 
QRISK and QRISK2 populations (2% and 0.7%), cardiovascular risk 
prediction in this cohort imprecise may be imprecise (Hippisley-Cox 
et al., 2008, 2010, 2017). Further research has demonstrated 
under-estimation of CVD risk in South Asian patients, and together with 
the increasing burden of cardiovascular disease in this population, we 
believe it is essential to develop population specific cardiovascular risk 
scores to improve the precision of cardiovascular risk assessment 
(Bhopal et al., 2005; Robson, Hippisley-Cox, & Coupland, 2012; Tillin 
et al., 2014). There are limited studies comparing different CVD pre-
diction models to South Asians residing in India and in the West, with all 
the major cardiovascular risk models studied developed in the general 
Caucasian population. Similarly, there is a paucity of evidence assessing 
the impact of migration upon cardiovascular risk evaluation, especially 
direct comparisons between native and migration populations. There-
fore, through our research we seek to address the gap in the knowledge 
of cardiovascular risk and aim to improve the accuracy of the current 
risk scores within ethnic populations (Bhopal et al., 2005; Cappuccio, 
Oakeshott, Strazzullo, & Kerry, 2002). 
The primary aim of this study was to evaluate 4 recognised and 
validated (in the western population) cardiovascular risk models in 
South Asians. By retrospectively analysing the cardiovascular risk pro-
file of South Asian patients as they presented with their first myocardial 
infarction (MI), we sought to assess agreement between the risk scores, 
had these patients presented in clinic immediately prior to their index 
event. Our objective was to analyse data from migrant South Asians 
resident in the United Kingdom (UK), then comparing this with existing 
data from native South Asians in India(Bansal, Kasliwal, & Trehan, 
2014), with the aim of evaluating discrepancies in risk assessment be-
tween the four major cardiovascular risk models. 
2. Methods 
This retrospective cohort analysis included 103 patients of South 
Asian background presenting to the Freeman Hospital, Newcastle-upon- 
Tyne with acute MI, from January 2009 to January 2015. Patients 
identified using Patient Analysis & Tracking System (PATS, Dendrite 
Clinical Systems Ltd, Playhatch, UK) were only included if they had no 
prior history of MI or stroke, and had a comprehensive cardiovascular 
risk factor assessment to allow risk score calculations. Of 103 patients, 
23 were excluded either for having a previously recorded acute coronary 
syndrome (ACS) or an incomplete dataset to enable a complete risk 
assessment. A total of 80 patients were followed up for a minimum of 6 
months to establish post MI mortality status, with hospital records 
accessed to ensure comprehensive data collection. 
For the purposes of the study, acute MI was defined according to the 
third universal definition of myocardial infarction released in 2012 by 
the ESC/ACCF/AHA/WHF (Thygesen et al., 2012) and patients classi-
fied as either ST-elevation MI (STEMI) or non-ST elevation MI 
(NSTEMI). 
Patients were admitted to the coronary care unit, clinically evaluated 
through history and physical examination and treated in accordance 
with National and European Guidelines (Hamm CW BJ-Pea, 2011; 
Myocardial infarction wit, 2012; Steg et al., 2011; Unstable angina 
andM, 2011). All 80 UK-based patients underwent percutaneous coro-
nary intervention (PCI). Data not available were length of stay in the UK, 
diet, exercise and socio-economic class. 
Four risk scores were used to evaluate cardiovascular risk: Fra-
mingham Risk Score (RiskFRS) (D’Agostino RB et al., 2008), World 
Health Organisation/International Society of Hypertension CVD risk 
prediction charts (RiskWHO) (World Health Organization, 2007), Amer-
ican College of Cardiology/American Heart Association (ACC/AHA) 
pooled cohort equations (RiskACC/AHA) (Goff et al., 2013b), and 3rd Joint 
British Societies’ risk calculator (RiskJBS) (Joint British Societies’, 2014). 
For RiskWHO, the South-East Asian region D chart was used. Based upon 
individual data, a 10-year risk percentage of having a major cardio-
vascular event (MI or stroke) was calculated for each patient, prior to 
their index acute MI presentation. 
Whilst all other risk scores calculate absolute values, RiskWHO pre-
diction tables only provide approximate ranges for 10-year risk esti-
mates; therefore risk categories for each model were constructed 
(<10%, 10–19.9%, 20–29.9%, 30–39.9%, >40%) to facilitate 
comparison. 
Table 1 compares the various clinical and biochemical parameters 
included in the 4 risk models (Bansal et al., 2014). 
To ensure calculation of a 10-year risk, the following adjustments 
were made during data input for all four risk scores: for patients aged 
above the specified range (see Table 1), the highest value possible was 
used e.g. RiskFRS - 74 years, with a similar strategy adapted to blood 
pressure and cholesterol values outside their respective reference 
ranges. 
Data from our UK-based cohort was directly compared with a cohort 
of 149 resident Indian patients also presenting with acute MI. The 
baseline characteristics of this population are included in Table 2, with 
hypertension (57.7%), diabetes (46.3%), smoking (27.5%) and prema-
ture CV disease (23.5%) being the most prevalent cardiovascular risk 
factors. The 10-year cardiovascular risk of this population was similarly 
evaluated using the same four major risk algorithms and compared to 
Table 1 
Clinical and biochemical parameters (with applicable ranges) included in 
various cardiovascular risk assessment models.  
Variable FRS JBS ACC/AHA WHO 
Age Yes (30–74 
years) 
Yes (30–84 
years) 
Yes (20–79 
years) 
Yes (35–75 
years) 
Gender Yes Yes Yes Yes 
Ethnicity No Yes Yes No 
History of diabetes Yes Yes Yes Yes 
Smoking history Yes Yes Yes Yes 
Family history of 
premature CVD 
No Yes No No 
History of atrial 
fibrillation 
No Yes No No 
History of chronic 
kidney disease 
No Yes No No 
History of 
rheumatoid 
arthritis 
No Yes No No 
History of blood 
pressure 
treatment 
Yes Yes Yes No 
Systolic blood 
pressure 
Yes 
(90–200 
mmHg) 
Yes 
(70–210 
mmHg) 
Yes 
(90–200 
mmHg) 
Yes 
(110–190 
mmHg) 
Body-mass index No Yes 
(20–50 kg/ 
m2) 
No No 
Total cholesterol Yes 
(100–405 
mg/dl) 
Yesa Yes 
(130–320 
mg/dl) 
Yes 
(3.5–8.5 
mmol/L) 
HDL cholesterol Yes 
(10–100 
mg/dl) 
Yesa Yes 
(20–100 
mg/dl) 
No 
Total number of risk 
factors included 
within the 
algorithm 
7 14 9 5 
**Units in brackets refers to the reference ranges considered in each algorithm. 
a The risk calculator accepts all usually found values of total and HDL- 
cholesterol but when total cholesterol exceeds 7.5 mmol/L, it highlights the 
possibility of familial hypercholesterolemia. ACC, American College of Cardi-
ology; AHA, American Heart Association; CVD, cardiovascular disease; FRS, 
Framingham risk score; HDL, high-density lipoprotein; JBS, Joint British Soci-
ety; WHO, World Health Organization. 
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our migrant Indian population (Bansal et al., 2014). Data was collected 
using LibreOffice Calc (version 6) with statistical analysis conducted 
using GraphPad 6 and SPSS (version 24). P-values were calculated using 
unpaired t-test with Welch’s correction and Pearson’s chi-squared test. 
Graphs were assembled using Minitab (version 17). Kappa analysis was 
conducted to compare the results of the risk calculators. Using SPSS, 
cardiovascular risk factors were statistically adjusted for using linear 
regression whilst Levene’s F-test and independent samples t-test was 
performed to compare the two populations and determine the effect of 
migration upon cardiovascular risk prediction. 
3. Results 
3.1. Patient characteristics and CVD risk profile 
Cardiovascular risk estimates were calculated for all patients, as 
determined by the risk factors prior to their ACS. Table 1 compares the 
data input variables required for each cardiovascular risk model. 
We then compared our data set to those of Bansal M et al. (Bansal 
et al., 2014) who had performed an identical analysis in a similar patient 
population (i.e. those presenting with first ACS) but residing in India. 
Baseline characteristics of our UK-resident South Asian patients are 
represented in Table 2, with comparisons to the native Indian cohort. 
Statistically significant differences in baseline characteristics be-
tween the UK South Asian population and the Indian population was 
observed, with a higher incidence of familial premature CVD (52.5% vs. 
23.5%, p < 0.05), higher total cholesterol level (179  53mg/dl) and 
serum triglyceride (206.9  133.2mg/dL) in the UK-resident South 
Asians compared to resident Indians (145.2  44.0mg/dl, p < 0.05) and 
(139.3  79.5, p < 0.05) respectively. In either cohort, there were no 
patients who had previously been diagnosed with a stroke. 
Overall, 36 (45%) patients were diagnosed with ST-elevation MI, 
with 42% of these being localised to the anterior wall. All patients 
presenting with ST-elevation MI underwent primary PCI to at least one 
vessel, no patients received thrombolytic therapy and none underwent 
surgical revascularisation. Intra-procedure systolic/diastolic BP was 
higher in the UK population: 135.5  32.1/75.1  15.3 mm Hg, 
compared to 117.2  20.7/69.7  13.7 mmHg (p < 0.05) in the Indian 
group. Mean heart rate was higher in the Indian residents (89  17 vs. 
74.6  16.4 beats per minute, p < 0.05). 
Two patients of the total eighty died at 6 months follow-up, however 
these were non-cardiovascular related deaths. 
3.2. Estimated CVD risk and agreement across algorithms 
As shown in Tables 2 and 3 and Fig. 1, RiskWHO provided the lowest 
risk estimates, with 62.5% of patients estimated to be having <10% 10- 
year cardiovascular risk, with another 16.3% having a calculated 
10–19.9% risk. RiskJBS identified the highest proportion of patients as 
‘high risk’ (65% of subjects with >20% 10-year cardiovascular risk). 
These findings concurred with those observed in the native Indian 
cohort (figures in brackets). Due to RiskFRS combining the 30–39.9% and 
>40% categories, a comparative analysis between cardiovascular risk 
scores can be made using estimated risk thresholds of less than 20% and 
greater than 20%, therefore provide a more efficient and equitable tool 
for treatment decisions, these are included in Table 3 (Fig. 2). 
After RiskJBS, RiskFRS was the second most likely to identify patients 
as ‘high risk’ (36.25%) using the >20% risk category. Both RiskFRS and 
RiskJBS demonstrated an increased ability to detect ‘high cardiovascular 
risk’ (>20%) patients, 46.3% (38.3%, p  0.241) and 65% (55.9%, p 
0.224) respectively, when compared to data from native Indians (rep-
resented in brackets with p-values). RiskACC/AHA recognised 71.3% 
(69.8%, p  0.819) of patients as having a ‘low cardiovascular risk’ with 
estimated 10-year risk <20%. This agreed with a RiskWHO, which 
identified 78.8% (86.6%, p  0.125) of patients similarly as low car-
diovascular risk. 
Kappa analysis was also conducted to determine the inter-rater 
agreement between the risk algorithms for the migrant and native In-
dian populations. The migrant population demonstrated a range of 
0.11–0.28, whilst the native population ranged from 0.01 to 0.35, with 
p-values <0.05, both at the lower end of agreement. 
Following statistical adjustment for known cardiovascular risk fac-
tors, the CV risk scores of the native and migrant populations were 
compared for each of the four risk algorithms. The homogeneity of 
variances was tested using Levene’s F test, and independent samples t- 
test was used to test the hypothesis that migration of South Asian pa-
tients has an impact upon their predicted cardiovascular risk score when 
compared to the native South Asian population. From our analysis, 
RiskJBS was the only risk score to demonstrate that migrant patients 
were associated with a higher mean CV risk score (mean  23.7, SD 
23.6), compared with the native patient group (mean  23.6, SD  10.8, 
p < 0.05) following adjustment for all other known cardiovascular risk 
score included within the algorithms. Independent samples t-test was 
also associated with a statistically significant greater risk in the migrant 
population compared to the native population, with a mean difference of 
10.1 (CI  4.7–15.7) in favour of the migrant population. In contrast, the 
other CV risk scores, RiskACC/AHA, RiskFRS and RiskWHO, were not asso-
ciated with a statistically significant difference in cardiovascular risk 
scores between the migrant and native patients, therefore we were un-
able to reject the null hypothesis that migration does not have an impact 
upon CV risk score. (RiskACC/AHA migrant vs. native; mean  16.3, SD 
13.4 vs. 17.3, SD  9.1, p  0.54), (RiskFRS migrant vs. native; mean 
Table 2 
Clinical and biochemical characteristics comparing UK resident and India resi-
dent study populations (percentages in brackets).  
Parameter UK resident 
(n  80) 
India resident ( 
Hippisley-Cox et al., 
2008) (n  149) 
P 
values 
Age (years) 56.2  13.1 59.4  10.6 0.062 
Male Gender n (%) 61 (76.3) 123 (82.6) 0.253 
Hypertension n (%) 46 (57.5) 86 (57.7) 0.975 
Diabetes Mellitus n (%) 30 (37.5) 69 (46.3) 0.200 
Current Smokers n (%) 23 (28.8) 41 (27.5) 0.843 
Family History of 
premature CVD n (%) 
42 (52.5) 35 (23.5) <0.05 
Body-mass index (kg/m2) 27.3  4.5 24.9  4.3 <0.05 
Heart rate (beats/min) 74.6  16.4 89  17 <0.05 
Systolic blood pressure 
(mmHg) 
135.5 
32.1 
117.2  20.7 <0.05 
Diastolic blood Pressure 
(mmHg) 
75.1  15.3 69.7  13.7 <0.05 
Types of Myocardial 
Infarction:   
<0.05 
STEMI 36 (45.0) 123 (82.6)  
Non-STEMI 44 (55.0) 26 (17.4) 
Location of myocardial 
infarction (STEMI) only    
Anterior wall myocardial 
infarction 
15 (41.7) 80 (65.0) <0.05 
Others 65 (81.3) 43 (35.0)  
Thrombolysis 0 37 (24.8) <0.05 
Percutaneous or surgical 
coronary 
revascularisation 
74 (92.5) 129 (86.6) 0.178 
STEMI Patients undergoing 
PCI (%) 
36 (100) _ _ 
Fasting blood glucose (mg/ 
dL) 
160.1 
87.5 
140.9  44.7 0.069 
Total cholesterol (mg/dL) 179.0 
53.0 
145.2  44.0 <0.05 
Serum Triglycerides (mg/ 
dL) 
206.9 
133.2 
139.3  79.5 <0.05 
HDL-cholesterol (mg/dL) 42.3  12.9 35.1  11.3 <0.05 
LDL-cholesterol (mg/dL) _ 88.6  35.9 _ 
P-values were calculated using unpaired t-test with Welch’s correction and 
Pearson’s chi-squared test. 
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2.6, SD  1.05 vs. 2.4, SD  0.8, p  0.22), (RiskWHO migrant vs. native; 
mean  1.9, SD  1.1 vs. 1.6, SD  0.7, p  0.07). 
4. Discussion 
The South Asian population is recognised for its predisposition to 
premature cardiovascular disease and propensity to exhibit multiple 
cardiovascular risk factors (Gupta & Brister, 2006; Joshi et al., 2007). 
Accurate cardiovascular risk estimation is essential given the impor-
tance of decision making for initiating preventative treatment strategies. 
Earlier comparative studies evaluating some cardiovascular risk calcu-
lators have highlighted their poor performance when analysing ethnic 
groups, whilst discrepancies between risk scoring models in Caucasian 
populations strongly emphasise the need for direct comparative studies 
and prospective validation studies to improve CV risk prediction (Collins 
& Altman, 2010; Siontis, Tzoulaki, Siontis, & Ioannidis, 2012; Tillin 
et al., 2014). The results of our research demonstrate significant vari-
ability between the four risk prediction models when estimating 10-year 
cardiovascular risk, confirming the challenges when identifying patients 
with high cardiovascular risk in the South Asian population. 
RiskJBS identified the highest proportion of UK-based South Asian 
patients as having high cardiovascular risk (65%), whilst RiskACC/AHA 
and RiskWHO using the same patient population, identified only 28.7% 
and 21.3% respectively as high risk. Importantly, this large variability 
between risk prediction models is supported by results of Bansal and co- 
workers who reported similar findings through their identical analysis of 
a native South Asian population. Bansal M et al. also demonstrated that 
RiskJBS recognised a higher proportion of ‘high cardiovascular risk’ 
South Asian patients when compared to RiskWHO and RiskACC/AHA, 
which reclassified a significant proportion of the same patients as low 
risk. With poor agreement between the individual risk scores, this will 
lead to potential inaccuracies in cardiovascular risk estimation if 
different risk scores are utilised, with relative under or overestimation of 
risk prediction. This could lead to major inconsistencies in healthcare 
advice and influence treatment decisions, in a population already rec-
ognised as having a high prevalence of premature onset CVD. 
There is recognition of a shortage of cardiovascular cohort studies in 
South Asian populations, particularly prospective studies (Ranganathan 
& Bhopal, 2006). Results from Kanjilala et al. concluded that despite a 
patient cohort with perceived high cardiovascular risk, only 5.3% were 
classified according to RiskFRS as ‘high risk’ (Kanjilal et al., 2008). The 
other risk scores utilised in the study, SCORE and JBS, identified less 
than 5% of patients as high risk, which appears to significantly under-
estimate 10-year cardiovascular risk in a population acknowledged as 
Table 3 
The estimated 10-year cardiovascular risk according to the four risk assessment models inc division into two risk categories as <20% and 20% (figures in second 
columns represent data from Bansal M et al. accompanied by p-values comparing the two data sets).  
Risk Category 
(%) 
FRS JBS ACC/AHA WHO 
Study Migrant Bansal et al. p-value Migrant Bansal et al. p-value Migrant Bansal et al. p-value Migrant Bansal et al. p-value 
<10 24% 22.8% p  0.873 18% 19.4% p  0.754 48% 38.3% p  0.176 63% 61.7% p  0.911 
10–19.9 30% 38.9% p  0.179 18% 24.7% p  0.247 24% 31.5% p  0.214 16% 24.8% p  0.134 
20–29.9 10% 13.4% p  0.451 20% 20.4% p  0.944 14% 15.4% p  0.732 3% 6.7% p  0.173 
30–39.9 36% 24.8% p  0.069 10% 17.2% p  0.172 6% 5.4% p  0.784 6% 6.7% p  0.615 
>40 _ _ _ 35% 18.3% p < 0.05 9% 9.4% p  0.872 13% 2.0% p < 0.05 
<20 54% 61.7% p  0.241 35% 44.1% p  0.224 71% 69.8% p  0.819 79% 86.6% p  0.125 
20 46% 38.3% p  0.241 65% 55.9% p  0.224 29% 30.2% p  0.819 21% 13.4% p  0.125 
Pearson’s chi-squared test was used to calculate p-values. 
Fig. 1. Four risk assessment models with estimated 10-year risk assessment models. Two categories for FRS combined (30–39.9% and 40% or more), as risk score 
does not provide values above 30% 10-year risk. Framingham Risk Score (FRS); Joint British Society (JBS); American College of Cardiology/American Heart As-
sociation (ACC/AHA); World Health Organisation (WHO). 
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having multiple cardiovascular risk factors equating to an increased CV 
risk burden. Despite similar research supporting the hypothesis of risk 
calculations underestimating overall cardiovascular risk in South Asians 
(Bansal, Shrivastava, Mehrotra, Agarwal, & Kasliwal, 2009; Cappuccio 
et al., 2002), there remains a shortage of cohort studies analysing car-
diovascular risk in ethnic populations, particularly within Europe 
(Ranganathan & Bhopal, 2006). This may explain the poor discrimina-
tion between observed CV events and estimated CV risk in South Asian 
populations, with some risk models having been developed in relatively 
small, homogenous, white populations rather than incorporating data 
specifically from our target population. By contrast, RiskJBS was devel-
oped taking data from the QRISK2 cohort of UK-based patients, which 
included 320,018 in the derivation and 95,983 South Asian patients in 
the validation cohorts (Hippisley-Cox et al., 2008, 2010, 2017). How-
ever despite these modifications, the proportion of South Asian patients 
included in these large cohorts remains low with the proportion of South 
Asians in the QRISK cohort representing only 4.1% and 3.6% of the total 
population in the derivation and validation cohorts respectively (Hip-
pisley-Cox et al., 2008, 2010, 2017). Tillin et al. underlines the caveats 
of these relatively small proportions, with their research evaluating the 
performance of QRISK 2 and Framingham risk scores in UK-based ethnic 
populations, which included a South Asian cohort representative of 36% 
of the study population (Tillin et al., 2014). Both risk scores were shown 
to underestimate cardiovascular risk in South Asian patients when 
assessing primary cardiovascular events at follow-up (Tillin et al., 
2014). As neither score performed well in the ethnic groups evaluated 
(South Asian and African Caribbean) it challenges the accuracy of the 
risk scores, whilst adding complexity to the extrapolation of risk score 
outcomes into South Asian populations. 
Despite these concerns, the accuracy of cardiovascular risk assess-
ment continues to improve, with newer risk models demonstrating a 
greater ability to distinguish high and low risk patients (Hippisley-Cox 
et al., 2008; Rao et al., 2012). As a consequence of the changing popu-
lation demographics and the increasing validation data available, newer 
risk models are now able to incorporate additional CV risk factors such 
as socio-economic status, BMI and ethnicity into their algorithms. 
Although none of the CV risk models used in our study originated from 
South Asian populations, South Asians are now being recognised within 
these predominantly Caucasian study cohorts. This conveys significant 
implications for the South Asian population, as we seek to establish the 
relevance of predictive CV risk scores for these patients, whilst providing 
the foundations to develop population specific CV risk scores, especially 
given their increased burden of cardiovascular risk and susceptibility to 
premature CV events (Krishnan, 2012). 
As supported by the results of our study, South Asian patients are 
recognised as having greater propensity to central obesity, increased 
prevalence of type 2 diabetes mellitus and greater number of CV risk 
factors, all leading to development of cardiovascular disease at a 
younger age compared to their Western comparators (Joshi et al., 2007). 
Of the cardiovascular risk models analysed, RiskJBS is the only risk 
model to incorporate statistical adjustment specifically for South Asian 
subjects, therefore strengthening cardiovascular risk estimation in this 
ethnic population. Not only does our study emphasise the high cardio-
vascular risk factor burden in South Asian patients, our research pro-
vides impetus to evaluate whether long term residency enhances or 
detracts from an algorithm’s predictive accuracy. In addition to making 
statistical adjustments for South Asian ethnicity, we note in our analysis 
that RiskJBS collects more data variables (e.g. atrial fibrillation, chronic 
kidney disease, family history) when calculating its cardiovascular risk 
estimate, which may further enhance the accuracy of this risk score 
therefore making it the strongest predictor score. To further evaluate the 
predictive accuracy of the four risk algorithms from our study, 
comparative analysis with a cohort of South Asians without cardiovas-
cular disease is required to enable calculation of other accuracy mea-
sures such as specificity and positive predictive value. This would add to 
the sensitivity analysis of our data, whilst also seeking to inform how 
migration impacts predictive accuracy of cardiovascular risk 
assessment. 
An estimated 10-year cardiovascular risk score >20% is classified as 
‘high risk’, and is indication for commencing primary prevention (Tillin 
et al., 2014; Bansal et al., 2014). The importance of accurately assessing 
a patient’s cardiovascular risk has prognostic benefits as early inter-
vention can prevent development of premature CVD, with targeted 
prevention strategies reducing CV-related morbidity and mortality. With 
South Asian populations having an increased prevalence of metabolic 
syndrome and glucose intolerance compared to the Caucasian 
Fig. 2. Estimated cardiovascular risk divided into <20% and 20% categories extrapolated from Table 3: Framingham Risk Score (FRS); Joint British Society (JBS); 
American College of Cardiology/American Heart Association (ACC/AHA); World Health Organisation (WHO). 
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population (39% vs 20%) (Ajjan, Carter, Somani, Kain, & Grant, 2007), 
their risk of developing premature CVD is significantly increased. One 
important finding between the native and UK South Asian populations in 
our study was the high prevalence of diabetes between the two groups 
compared to historical data in the Caucasian population with STEMI 
(Koshy, Balasubramaniam, Noman, & Zaman, 2014). A study from 
Barnett et al. not only demonstrated the increased prevalence of diabetes 
in the UK-based South Asian population, they also observed elevated 
triglycerides and lower HDL in this population, a finding supported by 
Hussain et al. (Barnett et al., 2006; Hussain, Oldenburg, Wang, Zoungas, 
& Tonkin, 2013) Whilst our sample size is small, prevalence of 37.5% in 
the UK and 46.3% in the native Asian population, compared with a 
diabetes prevalence of 10.5% in the Caucasian STEMI population re-
flects the growing burden of type 2 diabetes mellitus in South Asia. This 
finding in a small sample size provides pilot data for further studies of 
diabetes prevalence and outcomes in the native and migrant South Asian 
populations. This data also reaffirms the importance of accurate risk 
assessment and targeted prevention, with patients presenting at a 
younger age and with multiple CV risk factors whilst also highlighting 
the potential under-diagnosis of CVD in South Asians (Gupta, Singh, & 
Verma, 2006; Teoh, Lalondrelle, Roughton, Grocott-Mason, & Dubrey, 
2007). 
The results from our study show that RiskJBS, the cardiovascular risk 
model which include South Asian ethnicity as a discriminant risk factor, 
considered a higher proportion of South Asian patients as ‘high cardio-
vascular risk’ when compared against RiskFRS, and RiskACC/AHA. One 
would expect RiskJBS to provide the most accurate cardiovascular risk 
estimates in this study as it most closely reflects our study cohort, having 
been designed for a UK-based population and importantly includes 
validation data for South Asian patients. Whereas other risk models 
which have not been validated in South Asians, have been shown to have 
a tendency to underestimate cardiovascular risk within this target 
population (Rao et al., 2012; Robson et al., 2012). Furthermore, our 
study compared prominent cardiovascular risk factors such hyperten-
sion, smoking and diabetes mellitus between the native and migrant 
South Asian populations. These major cardiovascular risk factors pro-
vide the basis for the risk calculator algorithms, and whilst there are 
differences detailed in Table 2, they were not statistically significant. 
Therefore, when comparing the estimated 10 year cardiovascular risk 
scores between the two populations, no significant difference between 
cardiovascular risk was observed except for RiskJBS and RiskWHO 
(Table 3) in high risk patients (risk category >40%). 
RiskJBS would be expected to estimate cardiovascular risk more 
accurately than other scores given its multi-variable risk assessment, 
together with the continued risk score validation JBS conducts in 
response to changing population demographics and improved clinical 
outcomes (Collins & Altman, 2010). The RiskJBS algorithm derives from 
QRISK data, evaluating a large primary care population to construct the 
patient risk scores whilst incorporating additional CV risk factors such as 
family history, socioeconomic status and body mass index. RiskFRS and 
RiskWHO by contrast demonstrated the lowest proportion of patients to 
be classified as ‘high cardiovascular risk. Although RiskWHO algorithms 
identify specific sub-regions, they have not evaluated cardiovascular 
risk for individual countries which may influence their precision of es-
timate cardiovascular risk estimation. Whilst it may still be useful for 
broad patient risk stratification, RiskWHO tables have not been evaluated 
prospectively for CV risk assessment and lacks the necessary statistical 
risk adjustment for validated risk factors including chronic kidney dis-
ease, family history and body mass index, which could affect its accu-
racy and clinical decision support (Garg et al., 2017). Moreover, RiskFRS 
derives from a small, homogenous white population, perhaps limiting its 
applicability to our ethnic population, with independent validation 
studies demonstrating QRISK and QRISK 2 (from which JBS3 originates) 
superior to the Framingham risk score (Collins and Altman, 2009, 2010). 
RiskACC/AHA acknowledge within their practice guidelines the inaccur-
acies incurred when evaluated cardiovascular risk in ethnic populations, 
and whilst including statistical adjustment for Asian-American pop-
ulations, their lack of validation in South Asian patients may account for 
discrepancies when compared to other risk scores such as RiskJBS (Goff 
et al., 2013c). 
Whilst data exists demonstrating the baseline CVD risk in South 
Asian patients, with prevalence for coronary heart disease and stroke in 
South Asians males being 4.9%, compared to the general UK population 
3.2%, validating our research directly against a low-risk UK-based South 
Asian patient cohort would strengthen our findings and enable us to 
fully evaluate the accuracy of the risk models studied (Brindle et al., 
2006). The significant variability between the risk scores, particularly 
RiskJBS and RiskACC/AHA, which both provide statistical adjustment for 
South Asian populations, emphasises the discrepancy between the cur-
rent risk scores and the potential inaccuracies of cardiovascular risk 
profiling. Given the growing burden of CVD in Asian countries and 
different population characteristics, there is an urgent need for popu-
lation specific CVD risk models, which are essential to identify high risk 
patients and provide the basis for treatment decisions. 
The results of our independent samples t-test to assess the impact of 
migration upon cardiovascular risk prediction established that RiskJBS 
was the only risk algorithm with a statistically significant increase in 
cardiovascular risk in the migrant South Asian population compared 
with the native population. The other risk scores demonstrated no dif-
ference in cardiovascular risk estimate between the two populations. We 
recognise that larger multi-site prospective observational studies, with 
greater ethnic representation would be required to determine the sig-
nificance of these findings and provide stimulus for South Asian-based 
cardiovascular risk models. A comparison with the broader UK popu-
lation, including patients with and without cardiovascular disease, 
would support a valuable sensitivity and specificity analyses to deter-
mine the predicative accuracy of the cardiovascular risk scores, there-
fore enhancing the results of our research. 
5. Limitations 
There are several limitations of our pilot study. Firstly, whilst the 
numbers of patients in our study is small, our findings nevertheless 
provide preliminary data to support further studies. Although predictive 
accuracy of risk scores would be best conducted through a prospective 
observational study design, the caveat of this is the variability in 
exposure to baseline characteristics and the length of study conducted. 
All of our patients were UK resident but the length of time that 
subjects had spent in the UK was unknown. Calculated risk for South 
Asian patients may be influenced by time spent in the adopted country 
impacting upon CV risk factors which include socio-economic status, 
access to healthcare resources, diet and exercise. 
Our study included only patients from a single centre who developed 
acute myocardial infarction. To better calibrate the risk scores and 
determine their full accuracy, opening our study to multiple cardiology 
centres with inclusion of a low cardiovascular risk cohort would allow 
calculation of sensitivity and specificity, therefore assess validity and 
predictive accuracy of the algorithms. This would also enable us to 
evaluate the impact of long-term residency upon the algorithms’ pre-
dictive accuracy and analyse whether migration influences cardiovas-
cular risk estimation. 
Finally, heterogeneity in the definition of total CVD exists between 
the four considered risk models i.e. RiskWHO predicts for 10-year risk of 
fatal or non-fatal major cardiovascular event (myocardial infarction or 
stroke), whereas RiskFRS evaluates for 10-year risk of myocardial 
infarction. These differences in CVD outcomes measures could alter the 
sensitivity of the algorithms among ethnic populations, therefore 
influencing risk assessment recommendations and clinical decision 
making. Risk estimations may be also affected by adjustments to certain 
demographics falling outside the risk calculator range (e.g. age 30–74); 
however the closest value in these cases was used for our calculations. 
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6. Conclusion 
Our study evaluated the agreement between four prominent car-
diovascular risk scores, by retrospective analysis of patient data post 
myocardial infarction. The benefit to individuals, societies and health-
care systems of preventing CV events through the modification of risk 
factors is well known. Whilst risk scores can inform clinical decision 
making, the importance of applying clinical judgement to individual 
patients remains paramount. Our study supports the case for using South 
Asian specific CV risk scores, in a population where increased cardio-
vascular risk is recognised. This is especially relevant given the low 
numbers of published cohort studies that include South Asian pop-
ulations, and the differences observed between estimations calculated 
from CV risk scores. Our study demonstrates that accurately predicting 
cardiovascular risk in South Asian populations remains challenging. We 
conclude that for UK-resident South Asian patients, marked variations 
exist between CV risk prediction models. Further prospective studies are 
required to validate our research, with impetus to include larger cohorts 
of South Asian patients to best support clinical decision making. The 
results of our study provide pilot data for further research into diabetes 
prevalence and cardiovascular outcomes in South Asian populations. 
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